Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 3906425, 10 pages
http://dx.doi.org/10.1155/2016/3906425
Research Article

Abnormal Glucose Tolerance Is Associated with a Reduced Myocardial Metabolic Flexibility in Patients with Dilated Cardiomyopathy

1Dipartimento di Medicina Clinica e Sperimentale, Via Roma 67, 56126 Pisa, Italy
2National Research Council, Institute of Clinical Physiology, Pisa, Italy

Received 16 May 2015; Accepted 31 August 2015

Academic Editor: Zhenwu Zhuang

Copyright © 2016 Domenico Tricò et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. B. Kannel, M. Hjortland, and W. P. Castelli, “Role of diabetes in congestive heart failure: the Framingham study,” The American Journal of Cardiology, vol. 34, no. 1, pp. 29–34, 1974. View at Publisher · View at Google Scholar · View at Scopus
  2. A. G. Bertoni, W. G. Hundley, M. W. Massing, D. E. Bonds, G. L. Burke, and D. C. Goff Jr., “Heart failure prevalence, incidence, and mortality in the elderly with diabetes,” Diabetes Care, vol. 27, no. 3, pp. 699–703, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Nichols, C. M. Gullion, C. E. Koro, S. A. Ephross, and J. B. Brown, “The incidence of congestive heart failure in type 2 diabetes: an update,” Diabetes Care, vol. 27, no. 8, pp. 1879–1884, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. G. Bertoni, A. Tsai, E. K. Kasper, and F. L. Brancati, “Diabetes and idiopatihic cardiomyopathy: a nationwide case-control study,” Diabetes Care, vol. 26, no. 10, pp. 2791–2795, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. AlZadjali, V. Godfrey, F. Khan et al., “Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure,” Journal of the American College of Cardiology, vol. 53, no. 9, pp. 747–753, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Ashrafian, M. P. Frenneaux, and L. H. Opie, “Metabolic mechanisms in heart failure,” Circulation, vol. 116, no. 4, pp. 434–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk, “Myocardial substrate metabolism in the normal and failing heart,” Physiological Reviews, vol. 85, no. 3, pp. 1093–1129, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Neglia, A. de Caterina, P. Marraccini et al., “Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 6, pp. H3270–H3278, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. V. G. Dávila-Román, G. Vedala, P. Herrero et al., “Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy,” Journal of the American College of Cardiology, vol. 40, no. 2, pp. 271–277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. L. R. Peterson, P. Herrero, K. B. Schechtman et al., “Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women,” Circulation, vol. 109, no. 18, pp. 2191–2196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal, and W. C. Stanley, “Myocardial fatty acid metabolism in health and disease,” Physiological Reviews, vol. 90, no. 1, pp. 207–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. S. Larsen and E. Aasum, “Metabolic (in)flexibility of the diabetic heart,” Cardiovascular Drugs and Therapy, vol. 22, no. 2, pp. 91–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. T. Turer, C. R. Malloy, C. B. Newgard, and M. V. Podgoreanu, “Energetics and metabolism in the failing heart: important but poorly understood,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 4, pp. 458–465, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Domanski, H. Krause-Steinrauf, P. Deedwania et al., “The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial,” Journal of the American College of Cardiology, vol. 42, no. 5, pp. 914–922, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. V. S. Issa, A. F. Amaral, F. D. Cruz et al., “Glycemia and prognosis of patients with chronic heart failure—subanalysis of the long-term prospective randomized controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients (remadhe) trial,” American Heart Journal, vol. 159, no. 1, pp. 90–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. C. Osorio, W. C. Stanley, A. Linke et al., “Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid x receptor-α in pacing-induced heart failure,” Circulation, vol. 106, no. 5, pp. 606–612, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. M. D. Cerqueira, N. J. Weissman, V. Dilsizian et al., “Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A Statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association,” Circulation, vol. 105, no. 4, pp. 539–542, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Pereztol-Valdés, J. Candell-Riera, C. Santana-Boado et al., “Correspondence between left ventricular 17 myocardial segments and coronary arteries,” European Heart Journal, vol. 26, no. 24, pp. 2637–2643, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. F. A. Recchia, J. C. Osorio, M. P. Chandler et al., “Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs,” American Journal of Physiology—Endocrinology and Metabolism, vol. 282, no. 1, pp. E197–E206, 2002. View at Google Scholar · View at Scopus
  20. E. Ferrannini, D. Santoro, R. Bonadonna, A. Natali, O. Parodi, and P. G. Camici, “Metabolic and hemodynamic effects of insulin on human hearts,” The American Journal of Physiology—Endocrinology & Metabolism, vol. 264, no. 2, pp. E308–E315, 1993. View at Google Scholar · View at Scopus
  21. E. Ferrannini, “The theoretical bases of indirect calorimetry: a review,” Metabolism, vol. 37, no. 3, pp. 287–301, 1988. View at Publisher · View at Google Scholar · View at Scopus
  22. J. A. Wisneski, E. W. Gertz, R. A. Neese, and M. Mayr, “Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans,” The Journal of Clinical Investigation, vol. 79, no. 2, pp. 359–366, 1987. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Funada, T. R. Betts, L. Hodson et al., “Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling,” PLoS ONE, vol. 4, no. 10, Article ID e7533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Camici, P. Marraccini, M. Marzilli et al., “Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans,” The American Journal of Physiology: Endocrinology and Metabolism, vol. 257, no. 3, part 1, pp. E309–E317, 1989. View at Google Scholar · View at Scopus
  25. J. P. Bagger, A. Thomassen, and T. T. Nielsen, “Cardiac energy metabolism in patients with chest pain and normal coronary angiograms,” The American Journal of Cardiology, vol. 85, no. 3, pp. 315–320, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Burkhoff, R. G. Weiss, S. P. Schulman, R. Kalil-Filho, T. Wannenburg, and G. Gerstenblith, “Influence of metabolic substrate on rat heart function and metabolism at different coronary flows,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 261, no. 3, pp. H741–H750, 1991. View at Google Scholar · View at Scopus
  27. P. K. Mazumder, B. T. O'Neill, M. W. Roberts et al., “Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts,” Diabetes, vol. 53, no. 9, pp. 2366–2374, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. A. N. Carley and D. L. Severson, “Fatty acid metabolism is enhanced in type 2 diabetic hearts,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1734, no. 2, pp. 112–126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Lei, V. Lionetti, M. E. Young et al., “Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure,” Journal of Molecular and Cellular Cardiology, vol. 36, no. 4, pp. 567–576, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. D. An and B. Rodrigues, “Role of changes in cardiac metabolism in development of diabetic cardiomyopathy,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 291, no. 4, pp. H1489–H1506, 2006. View at Publisher · View at Google Scholar · View at Scopus